The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksKanabo Grp Plc Regulatory News (KNB)

Share Price Information for Kanabo Grp Plc (KNB)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1.70
Bid: 1.50
Ask: 1.90
Change: 0.00 (0.00%)
Spread: 0.40 (26.667%)
Open: 1.70
High: 1.70
Low: 1.70
Prev. Close: 1.70
KNB Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Directorate Change

31 Mar 2023 14:40

RNS Number : 9997U
Kanabo Group PLC
31 March 2023
 

 

31 March 2023

 

Kanabo Group plc

("Kanabo", the "Group" or the "Company")

 

Directorate Change

 

Kanabo Group plc (LSE: KNB), a leading patient-focused healthtech ecosystem and provider of personalised medicinal treatments, announces that Dan Poulter has stepped down as Non-Executive Director ("NED") to focus on existing commitments outside of the business.

 

Kanabo is at very advanced stages of appointing a new UK-based NED to join the Board of Directors, and a further announcement about this will be made imminently.

 

David Tsur, Chairman of Kanabo, commented:

 

"I would like to thank Dan for his contribution to the Company. He has been a pleasure to work with and we wish him every success in the future."

 

 

Enquiries:

 

Kanabo Group plc

Avihu Tamir, Chief Executive Officer

Assaf Vardimon, Chief Financial Officer

 

 

via Vigo Consulting

+44 (0)20 7390 0230

Peterhouse Capital Ltd (Financial Adviser and Broker)

Eran Zucker/ Lucy Williams / Charles Goodfellow

 

+44 (0)20 7469 0930

Vigo Consulting (Financial Public Relations/Investor Relations)

Jeremy Garcia / Fiona Hetherington / Verity Snow

kanabo@vigoconsulting.com

 +44 (0)20 7390 0230

 

 

 

About Kanabo Group Plc

Founded in 2017, Kanabo Group Plc (LSE:KNB) is a patient-first HealthTech ecosystem, focused on delivering high quality and innovative medical treatments, via its leading-edge technology platform and disruptive product offering.

 

The Company is a world leader in the research, development and commercialization of regulated medicinal cannabis-derived formulations and therapeutic inhalation devices. 

 

Patient care is delivered via the company's NHS-approved online telehealth platform offering video consultations, online prescriptions and access to primary care services. In January 2023, the Company successfully combined its technological and product expertise to launch the Beta phase of its medical cannabis business, initially for chronic pain management, under the new Treat-It brand.

 

Kanabo Group is committed to evolving more accessible healthcare experiences for every patient.

 

Visit www.kanabogroup.com for more info.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOAFLFVVVIILVIV
Date   Source Headline
28th Mar 20247:00 amRNSExpansion of Treat It to Mental Health Treatments
27th Mar 20245:11 pmRNSHolding(s) in Company
25th Mar 20247:00 amRNSGermany Medical Cannabis Legislation Reform
18th Mar 20249:14 amRNSAgritec Update
15th Jan 20247:00 amRNSPartnership to launch a Walk-In Pain Clinic
14th Nov 20237:00 amRNSContract Extension With Major UK Retailer
2nd Nov 20237:00 amRNSPartnership with BRITISH CANNABISâ„¢
29th Sep 20237:00 amRNSHalf-Year Results
31st Aug 202311:13 amRNSTotal Voting Rights
11th Aug 202311:36 amRNSIssuance of New Ordinary Shares and TVR
26th Jul 20232:00 pmRNSAdmission and Total Voting Rights
24th Jul 20234:10 pmRNSIssuance of New Ordinary Shares and TVR
17th Jul 20237:00 amRNSSuccess for Kanabo Agritec with Contract Award
10th Jul 202311:19 amRNSIssue of New Ordinary Shares and TVR
30th Jun 20232:34 pmRNSResult of AGM
28th Jun 20237:00 amRNSIssue of New Ordinary Shares and TVR
23rd Jun 20237:00 amRNSGrant of Options
13th Jun 20232:39 pmRNSPublication of a Prospectus
8th Jun 20235:19 pmRNSNotice of Annual General Meeting
31st May 202311:30 amRNSTotal Voting Rights
26th May 202310:30 amRNSTotal Voting Rights
23rd May 202311:00 amRNSIssuance of New Ordinary Shares
16th May 20233:00 pmRNSUpdate: Amendments to Acquisition Agreement
16th May 20237:00 amRNSAmendments to Acquisition Agreement
15th May 20237:00 amRNSTotal Voting Rights
12th May 20237:00 amRNSTotal Voting Rights
10th May 20232:52 pmRNSResult of Broker Option
9th May 20237:00 amRNSAppointment of Ian Mattioli as Non-Executive Chair
9th May 20237:00 amRNSFundraise of £2.54 million and Broker Option
4th May 20234:45 pmRNSBoard Change
2nd May 20237:00 amRNSFull Year Results 2022
31st Mar 20232:40 pmRNSDirectorate Change
13th Mar 20237:00 amRNSTreat It Launch: Online Medicinal Cannabis Clinic
7th Mar 202312:15 pmRNSAppointment of Auditor
14th Feb 20234:40 pmRNSSecond Price Monitoring Extn
14th Feb 20234:35 pmRNSPrice Monitoring Extension
14th Feb 20237:00 amRNSBusiness Update
2nd Feb 20239:05 amRNSSecond Price Monitoring Extn
2nd Feb 20239:00 amRNSPrice Monitoring Extension
30th Jan 202311:05 amRNSSecond Price Monitoring Extn
30th Jan 202311:00 amRNSPrice Monitoring Extension
27th Jan 202311:05 amRNSSecond Price Monitoring Extn
27th Jan 202311:00 amRNSPrice Monitoring Extension
25th Jan 20232:05 pmRNSSecond Price Monitoring Extn
25th Jan 20232:00 pmRNSPrice Monitoring Extension
25th Jan 202311:05 amRNSSecond Price Monitoring Extn
25th Jan 202311:00 amRNSPrice Monitoring Extension
17th Jan 20237:00 amRNSLaunch of new products
30th Dec 20227:00 amRNSBoard Changes
2nd Dec 20222:59 pmRNSResignation of Auditor

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.